Myoclonus in childhood

Marsden, 1982, The nosology and pathophysiology of myoclonus, 196 Pranzatelli, 1993, Myoclonic disorders, Pediatr Ann, 22, 33, 10.3928/0090-4481-19930101-07 Tassinari, 1995, Epileptic negative myoclonus, Adv Neurol, 67, 181 Hallett, 1985, Myoclonus: Relation to epilepsy, Epilepsia, 26, 567, 10.1111/j.1528-1157.1985.tb05726.x Anstead, 2000, Pediatric sleep disorders: New developments and evolving understanding, Curr Opin Pulm Med, 6, 501, 10.1097/00063198-200011000-00007 Toro, 1993, Cortical tremor: A common manifestation of cortical myoclonus, Neurology, 43, 2346, 10.1212/WNL.43.11.2346 DiFazio, 1998, Acute myoclonus secondary to group A beta-hemolytic streptococcus infection: A PANDAS variant, J Child Neurol, 13, 516, 10.1177/088307389801301010 Maiteh, 2001, Myoclonic seizure following intravenous verapamil injection: Case report and review of the literature, Ann Trop Paediatr, 21, 271, 10.1080/02724930120077862 Grech, 2001, Temporary myoclonus with treatment of congenital transcobalamin 2 deficiency, Pediatr Neurol, 24, 75, 10.1016/S0887-8994(00)00235-6 Ozer, 2001, Involuntary movements in infantile cobalamin deficiency appearing after treatment, Pediatr Neurol, 25, 81, 10.1016/S0887-8994(01)00289-2 McClain, 2001, Intravenous clonidine use in a neonate experiencing opioid-induced myoclonus, Anesthesiology, 95, 549, 10.1097/00000542-200108000-00042 Mercadante, 2001, Gabapentin for opioid-related myoclonus in cancer patients, Support Care Cancer, 9, 205, 10.1007/s005200000230 Zaw, 2001, Flumazenil's reversal of myoclonic-like movements associated with midazolam in term newborns, Pharmacotherapy, 21, 642, 10.1592/phco.21.6.642.34545 Ghaziuddin, 2001, Myoclonus during prolonged treatment with sertraline in an adolescent patient, J Child Adolesc Psychopharmacol, 11, 199, 10.1089/104454601750284126 Daoust-Roy, 1992, Benign neonatal sleep myoclonus: A differential diagnosis of neonatal seizures, AJDC, 146, 1236 Bye, 2000, Paroxysmal non-epileptic events in children: A retrospective study over a period of 10 years, J Paediatr Child Health, 36, 244, 10.1046/j.1440-1754.2000.00496.x Maydell, 2001, Benign myoclonus of early infancy: An imitator of West's syndrome, J Child Neurol, 16, 109, 10.1177/088307380101600208 Rajakumar, 1996, Febrile myoclonus: A survey of pediatric neurologists, Clin Pediatr (Phila), 35, 331, 10.1177/000992289603500609 Pranzatelli, 2000, Paraneoplastic syndromes: An unsolved murder, Semin Pediatr Neurol, 7, 118, 10.1053/pb.2000.6695 Pranzatelli, 1995, The neuropharmacology of progressive myoclonus epilepsy: Response to 5-hydroxy-L-tryptophan, Epilepsia, 36, 783, 10.1111/j.1528-1157.1995.tb01615.x Berkovic, 1989, Myoclonus epilepsy and ragged-red fibres (MERRF), 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study, Brain, 112, 1231, 10.1093/brain/112.5.1231 Yoshimura, 2001, Long-term observations of two siblings with Lafora disease treated with zonisamide, Epilepsy Res, 46, 283, 10.1016/S0920-1211(01)00282-0 Tobimatsu, 1985, Electrophysiological studies of myoclonus in sialidosis type 2, Clin Neurophysiol, 60, 16, 10.1016/0013-4694(85)90944-7 Tomoda, 1991, Progressive myoclonus epilepsy: Dentato-rubro-pallido-luysian atrophy (DRPLA) in childhood, Brain Dev, 13, 266, 10.1016/S0387-7604(12)80061-1 Minassian, 1995, Genetics of myoclonus and myoclonus epilepsies, Clin Neurosci, 3, 223 Delgado-Escueta, 1999, Mapping and positional cloning of common idiopathic generalized epilepsies: Juvenile myoclonus epilepsy and childhood absence epilepsy, Adv Neurol, 79, 351 Pranzatelli, 2002, Infantile spasms vs. myoclonus: Is there a connection?, 285 Fejerman, 1997, Myoclonus and epilepsies, Indian J Pediatr, 64, 583, 10.1007/BF02726110 Oguni, 2001, Myoclonicastatic epilepsy of early childhood: Clinical and EEG analysis of myoclonic-astatic seizures, and discussions on the nosology of the syndrome, Brain Dev, 23, 757, 10.1016/S0387-7604(01)00281-9 Pagani, 2002, A new type of mutation carries a splicing defect in ATM, Nat Genet, 30, 426, 10.1038/ng858 Klein, 2000, A major focus for myoclonus-dystonia maps to chromosome 7q in eight families, Am J Hum Genet, 67, 1314 Pranzatelli, 1994, Serotonin and human myoclonus: Rationale for the use of serotonin receptor agonists and antagonists, Arch Neurol, 51, 605, 10.1001/archneur.1994.00540180083018 Shibasaki, 2000, Electrophysiological studies of myoclonus, Muscle Nerve, 23, 321, 10.1002/(SICI)1097-4598(200003)23:3<321::AID-MUS3>3.0.CO;2-3 Baumgartner, 1996, Epileptic negative myoclonus: An EEG-single-photon emission CT study indicating involvement of premotor cortex, Neurology, 46, 753, 10.1212/WNL.46.3.753 Pranzatelli, 1995, Mechanism of action of antiepileptic and antimyoclonic drugs, Adv Neurol, 67, 329 Pennacchio, 1996, Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1), Science, 271, 1731, 10.1126/science.271.5256.1731 Gupta, 2001, Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice, 98, 13566 Wallace, 2002, Animal models for mitochondrial disease, Methods Mol Biol, 197, 3 Cooper, 2002, Profound loss of GAB Aergic interneurons in the PPT1 knockout mouse model of infantile neuronal ceroid lipofuscinosis, Neuropathol Appl Neurobiol, 28, 158, 10.1046/j.1365-2990.2002.39286_29.x Chattopadhyay, 2002, An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease, Hum Mol Genet, 11, 1421, 10.1093/hmg/11.12.1421 Espinosa, 2001, Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3, J Neurol Sci, 21, 6657 Shibasaki, 1994, Cortical reflex negative myoclonus, Brain, 117, 477, 10.1093/brain/117.3.477 Guerrini, 1996, Cortical myoclonus in Angelman syndrome, Ann Neurol, 40, 39, 10.1002/ana.410400109 Guerrini, 2001, Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2, Brain, 124, 2459, 10.1093/brain/124.12.2459 Oguro, 1997, Opsoclonusmyoclonus syndrome with abnormal single photon emission computed tomography imaging, Pediatr Neurol, 16, 334, 10.1016/S0887-8994(97)00031-3 Tanaka, 1997, Recurrent pain attacks in a 3-year-old patient with myoclonus epilepsy associated with ragged-red fibers (MERRF): A single-photon emission computed tomographic (SPECT) and electrophysiological study, Brain Dev, 19, 205, 10.1016/S0387-7604(96)00558-X Gascon, 1994, Movement disorders in childhood organic acidurias: Clinical, neuroimaging, and biochemical correlations, Brain Dev, 16, 94, 10.1016/0387-7604(94)90102-3 Hyland, 1998, Defects of biopterin metabolism and biogenic amine biosynthesis: Clinical, diagnostic, and therapeutic aspects, Vol 78, 301 Schols, 1997, Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds, Arch Neurol, 54, 1073, 10.1001/archneur.1997.00550210011007 Bespalova, 1997, Novel cystatin B mutation and diagnostic PCR assay in Unverricht-Lundborg (Baltic) progressive myoclonus epilepsy patient, Am J Med Genet (Neuropsych Gen), 74, 467, 10.1002/(SICI)1096-8628(19970919)74:5<467::AID-AJMG1>3.0.CO;2-L Serratosa, 1999, A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2), Hum Mol Genet, 8, 345, 10.1093/hmg/8.2.345 Larson, 1999, Instability of the EPM1 minisatellite, Hum Mol Genet, 8, 1985, 10.1093/hmg/8.11.1985 Borner, 2000, Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients, Hum Mol Genet, 9, 467, 10.1093/hmg/9.4.467 Wisniewski, 2000, Neuronal ceroid lipofuscinoses: Research update, Neurol Sci, 21, 549 Bonten, 2000, Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis, Hum Mol Genet, 9, 2715, 10.1093/hmg/9.18.2715 Wood, 2000, Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription, J Cell Biol, 150, 939, 10.1083/jcb.150.5.939 Pshezhetsky, 2001, Lysosomal multienzyme complex: Biochemistry, genetics and molecular pathophysiology, Prog Nucleic Acid Res Mol Biol, 69, 81, 10.1016/S0079-6603(01)69045-7 Minassian, 2001, Lafora's disease: Towards a clinical, pathologic, and molecular synthesis, Pediatr Neurol, 25, 21, 10.1016/S0887-8994(00)00276-9 Zimprich, 2001, Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome, Nat Genet, 29, 66, 10.1038/ng709 Tate, 1995, A sensitive and semi-quantitative pediatric myoclonus evaluation scale, Neurosci Nurs, 27, 287, 10.1097/01376517-199510000-00009 Pranzatelli, 2001, Controlled pilot study of piracetam for pediatric opsoclonus-myoclonus, Clin Neuropharmacol, 24, 352, 10.1097/00002826-200111000-00007 Capovilla, 1999, Ethosuximide is effective in the treatment of epileptic negative myoclonus in childhood partial epilepsy, J Child Neurol, 14, 395, 10.1177/088307389901400609 Moretti, 2000, Opsoclonus-myoclonus syndrome: Gabapentin as a new therapeutic proposal, Eur J Neurol, 7, 455, 10.1046/j.1468-1331.2000.00091.x Wallace, 2001, Newer antiepileptic drugs: Advantages and disadvantages, Brain Dev, 23, 277, 10.1016/S0387-7604(01)00230-3 Eldridge, 1983, “Baltic” myoclonus epilepsy: Hereditary disorder of childhood made worse by phenytoin, Lancet, 9, 838, 10.1016/S0140-6736(83)90749-3 Marciani, 1995, Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: An electroencephalographic study, Acta Neurol Scand, 91, 1, 10.1111/j.1600-0404.1995.tb05834.x Guerrini, 1999, Myoclonic status epilepticus following high-dosage lamotrigine therapy, Brain Dev, 21, 420, 10.1016/S0387-7604(99)00048-0 Nanba, 1999, Epileptic negative myoclonus induced by carbamazepine in a child with BECTS: Benign childhood epilepsy with centrotemporal spikes, Pediatr Neurol, 21, 664, 10.1016/S0887-8994(99)00054-5 Asconape, 2000, Myoclonus associated with the use of gabapentin, Epilepsia, 41, 479, 10.1111/j.1528-1157.2000.tb00192.x Janszky, 2000, Disabling erratic myoclonus during lamotrigine therapy with high serum level: Report of two cases, Clin Neuropharmacol, 23, 86, 10.1097/00002826-200003000-00005 Huppertz, 2001, Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin, Epilepsia, 42, 790, 10.1046/j.1528-1157.2001.44000.x Yiu, 2001, Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome, Pediatr Neurol, 24, 72, 10.1016/S0887-8994(00)00227-7 Kompoliti, 1999, Estrogen and movement disorders, Clin Neuropharmacol, 22, 318 Gouliaev, 1994, Piracetam and other structurally related nootropics, Brain Res Rev, 19, 180, 10.1016/0165-0173(94)90011-6 Ikeda, 1996, Clinical trial of piracetam in patients with myoclonus: Nationwide multiinstitution study in Japan, Mov Disord, 11, 691, 10.1002/mds.870110615 Genton, 2000, Piracetam and levetiracetam: Close structural similarities but different pharmacological and clinical profiles, Epileptic Disord, 2, 99 Feddi, 2001, Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy, Arch Neurol, 58, 781, 10.1001/archneur.58.5.781 Krauss, 2001, Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam, Neurology, 56, 411, 10.1212/WNL.56.3.411 Pranzatelli, 2001, Chloral hydrate for progressive myoclonus epilepsy: A new look at an old drug, Pediatr Neurol, 25, 385, 10.1016/S0887-8994(01)00350-2 Awaad, 1999, Treatment of childhood myoclonus with botulinum toxin type A, J Child Neurol, 14, 781, 10.1177/088307389901401203 Chen, 2000, Studies of human motor physiology with transcranial magnetic stimulation, Muscle Nerve Suppl, 9, S26, 10.1002/1097-4598(2000)999:9<::AID-MUS6>3.0.CO;2-I Amassian, 1995, Some positive effects of transcranial magnetic stimulation, Adv Neurol, 67, 79 Triggs, 2001, Improving brain function with transcranial magnetic stimulation, Neurology, 56, 429, 10.1212/WNL.56.4.429 McDonald, 2000, Electroconvulsive therapy in the treatment of neuropsychiatric conditions and transcranial magnetic stimulation as a pathophysiological probe in neuropsychiatry, Depress Anxiety, 12, 135, 10.1002/1520-6394(2000)12:3<135::AID-DA5>3.0.CO;2-4 Lisanby, 2001, Deliberate seizure induction with negative transcranial magnetic stimulation in nonhuman primates, Arch Gen Psychiatry, 58, 199, 10.1001/archpsyc.58.2.199